Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Magkouta, C. Moschos, M. Spella, M. E. Vazakidou, I. Psallidas, A. Pappas, G. Stathopoulos, I. Kalomenidis (Athens, Patras, Greece). Impact of angiopoietin-1 in mesothelioma progression. Eur Respir J 2013; 42: Suppl. 57, 1519

Member's Comments

No comment yet.

Related content which might interest you: Prognostic impact of histology and treatment modalities in malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Management of malignant mesothelioma Source: ERS Skills Course 2018 - Practical Pleural Skills Year: 2018 Predicting survival in malignant mesothelioma Source: Eur Respir J 2011; 38: 1420-1424 Year: 2011 Effect of asbestos on gene expression of tight junctions components in malignant pleural mesothelioma Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Prognostic characteristics of malignant pleural mesothelioma Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Mesothelioma Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Mesothelioma Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 Mesothelioma Source: Annual Congress 2008 - PG6 - Thoracic oncology: new treatments for thoracic malignancies (other than nonsmall cell lung cancer) Year: 2008 Mesothelioma Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Mesothelioma Source: ERS Skills Course 2016 Year: 2016 Role of fibulin-3 in the diagnosis of malignant mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Volume quantification of malignant pleural mesothelioma Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Tumour necrosis correlates with angiogenesis and is a prognostic factor in malignant mesothelioma Source: Eur Respir J 2002; 20: Suppl. 38, 232s Year: 2002 Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2003; 22: Suppl. 45, 62s Year: 2003 Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 755s Year: 2007 All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice Source: Eur Respir J 2009; 34: 1159-1167 Year: 2009 Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013